Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kagiava

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Toxicology in Vitro : an International Journal Published in Association with BIBRA|October 3, 2006
Assessing the effects of three dental impression materials on the isolated sciatic nerve of rat and frogA Andreou, N Dabarakis, A Kagiava, et al.
Scientific Reports|December 3, 2021
Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous deliveryA Kagiava, J Richter, C Tryfonos, et al.
Human Molecular Genetics|February 21, 2018
Intrathecal gene therapy in mouse models expressing CMT1X mutationsA Kagiava, C Karaiskos, J Richter, et al.
Human Molecular Genetics|August 15, 2019
Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1XA Kagiava, J Richter, C Tryfonos, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Toxicology in Vitro : an International Journal Published in Association with BIBRA|October 3, 2006
Assessing the effects of three dental impression materials on the isolated sciatic nerve of rat and frogA Andreou, N Dabarakis, A Kagiava, et al.
Scientific Reports|December 3, 2021
Efficacy of AAV serotypes to target Schwann cells after intrathecal and intravenous deliveryA Kagiava, J Richter, C Tryfonos, et al.
Human Molecular Genetics|February 21, 2018
Intrathecal gene therapy in mouse models expressing CMT1X mutationsA Kagiava, C Karaiskos, J Richter, et al.
Human Molecular Genetics|August 15, 2019
Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1XA Kagiava, J Richter, C Tryfonos, et al.
Pageof 1